1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co. Ltd.
  6. News
  7. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO. LTD.

(1099)
  Report
Delayed Hong Kong Stock Exchange  -  04:08 2022-08-12 am EDT
17.64 HKD   -0.45%
08/09SY Holdings Bags $6 Million Contract to Supply Sinopharm-Affiliated Hospitals with Software Systems
MT
07/08Sinopharm Mulls $1 Billion Purchase of DNA Products Supplier BBI Life Sciences
MT
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sinopharm Group Co. Ltd. Announces Executive Changes

06/17/2022 | 09:57am EDT

Sinopharm Group Co. Ltd. announced that due to attainment of the statutory retirement age, Mr. Zhang Hongyu tendered his resignation as an employee representative supervisor (the "Employee Representative Supervisor") of the Company, which shall take effect from 17 June 2022. On 17 June 2022, Mr. Liu Hongbing ("Mr. Liu") was elected as an Employee Representative Supervisor at the meeting of the employee representatives of the Company with immediate effect. In accordance with the articles of association of the Company, the Employee Representative Supervisor shall be elected democratically by the meeting of the employee representatives of the Company and is not subject to the approval of the Shareholders. Mr. Liu Hongbing, aged 51, has been a member of the Party Committee and the secretary of Discipline Inspection Commission of the Company since March 2021. Mr. Liu served in the army force from 1987 to 2019, and developed an in-depth study in the national policies. From January 2020 to March 2021, Mr. Liu acted as the director of the board office, head of the publicity department of the Party Committee and the director of press office, and concurrently served as the deputy officer of policy study office of China National Pharmaceutical Group Co. Ltd.


© S&P Capital IQ 2022
All news about SINOPHARM GROUP CO. LTD.
08/09SY Holdings Bags $6 Million Contract to Supply Sinopharm-Affiliated Hospitals with Soft..
MT
07/08Sinopharm Mulls $1 Billion Purchase of DNA Products Supplier BBI Life Sciences
MT
06/27SINOPHARM GROUP CO. LTD. : Ex-dividend day for final dividend
FA
06/23Sinopharm Group Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2021, ..
CI
06/21Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
06/17Sinopharm Group Co. Ltd. Announces Executive Changes
CI
06/10Sinopharm Group Co. Ltd. Announces Resignation of Deng Jindong as Member of Audit Commi..
CI
06/10ChromaDex Signs Tru Niagen Distribution Deal With Sinopharm Xingsha; Shares Climb Prema..
MT
06/02Sinopharm Group Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2021, ..
CI
05/19CanSino Biologics Rises After WHO Approves Covid Vaccine for Emergency Use
DJ
More news
Analyst Recommendations on SINOPHARM GROUP CO. LTD.
More recommendations
Financials
Sales 2022 576 B 85 464 M 85 464 M
Net income 2022 8 545 M 1 267 M 1 267 M
Net Debt 2022 22 148 M 3 285 M 3 285 M
P/E ratio 2022 5,53x
Yield 2022 5,40%
Capitalization 47 353 M 7 023 M 7 023 M
EV / Sales 2022 0,12x
EV / Sales 2023 0,12x
Nbr of Employees 113 234
Free-Float 43,0%
Chart SINOPHARM GROUP CO. LTD.
Duration : Period :
Sinopharm Group Co. Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO. LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 15,17 CNY
Average target price 20,28 CNY
Spread / Average Target 33,6%
EPS Revisions
Managers and Directors
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board
Sector and Competitors